EUVIMEDEUVIMED entdecken
Open Access

Disrupting CARMA3 Signaling with Triptolide Reverses Sorafenib Resistance in Hepatocellular Carcinoma

Wan-Yu Wang, Tung-Wei Hsu, Yen-Hao Su, Chih-Ming Su, Tzu-Hsuan Wang, Ching-Feng Chiu, Kuei-Yen Tsai, Chih-Yang Huang, Hsin-An Chen, Po-Hsiang Liao

International Journal of Medical Sciences · 2025

DOI: 10.7150/ijms.121880 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Medical Sciences, 2025. Verfasst von Wan-Yu Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of General Surgery, Department of Surgery, Shuang Ho Hospital, Taipei Medical University, New Taipei City 235, Taiwan. Hauptthemen laut MEDLINE: Phenanthrenes, Diterpenes, Carcinoma, Hepatocellular, Liver Neoplasms. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhenanthrenesDiterpenesCarcinoma, HepatocellularLiver NeoplasmsDrug Resistance, NeoplasmSorafenibHumansEpoxy CompoundsSignal TransductionReactive Oxygen SpeciesCell Line, TumorXenograft Model Antitumor AssaysGene Expression Regulation, NeoplasticAnimalsMice

Stichwörter der Autor:innen

CARMA3chemoresistancehepatocellular carcinomasorafenibtriptolide

Substanzen

triptolidePhenanthrenesDiterpenesEpoxy CompoundsSorafenibReactive Oxygen Species

Autor:innen und Institutionen

  • Division of General Surgery, Department of Surgery, Shuang Ho Hospital, Taipei Medical University, New Taipei City 235, Taiwan.
  • Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.
  • TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 110, Taiwan.
  • Division of General Surgery, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.
  • TMU Research Center for Digestive Medicine, Taipei Medical University, Taipei 110, Taiwan.
  • Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.

Zitieren

APA

Wang, W. Y., Hsu, T. W., Su, Y. H., Su, C. M., Wang, T. H., Chiu, C. F., Tsai, K. Y., Huang, C. Y., Chen, H. A., & Liao, P. H. (2025). Disrupting CARMA3 Signaling with Triptolide Reverses Sorafenib Resistance in Hepatocellular Carcinoma. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.121880

Vancouver

Wang WY, Hsu TW, Su YH, Su CM, Wang TH, Chiu CF, et al. Disrupting CARMA3 Signaling with Triptolide Reverses Sorafenib Resistance in Hepatocellular Carcinoma. International Journal of Medical Sciences. 2025. doi:10.7150/ijms.121880

BibTeX
@article{Wang2025,
  author = {Wang, Wan-Yu and Hsu, Tung-Wei and Su, Yen-Hao and Su, Chih-Ming and Wang, Tzu-Hsuan and Chiu, Ching-Feng and Tsai, Kuei-Yen and Huang, Chih-Yang and Chen, Hsin-An and Liao, Po-Hsiang},
  title = {Disrupting CARMA3 Signaling with Triptolide Reverses Sorafenib Resistance in Hepatocellular Carcinoma},
  journal = {International Journal of Medical Sciences},
  year = {2025},
  doi = {10.7150/ijms.121880}
}
Kostenlos starten →